Status:
TERMINATED
Home Improvement Initiative of the TRaitement Optimisé Medicamenteux After Hospitalization
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Older Adult
Chronic Disease
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The hypothesis is that the intervention of an operational clinical pharmacy team (EOPC), targeting both patients and hospital and health care professionals, allows: i) to initiate a therapeutic review...
Eligibility Criteria
Inclusion
- Patient (man or woman)
- age ≥ 65 years with more than 3 drugs taken for 3 months, stay in surgery with a duration of ≥ 1 days including urgent surgery;
- affiliated to a social health insurance scheme;
- for whom a return home is possible;
- able to understand the objectives of the research and give informed, dated and signed consent.
Exclusion
- Patient (man or woman)
- with as a hospital discharge an entry into a nursing home or long-term care called "important medical and technical care (SMTI);
- with cognitive or other problems preventing consent (at the discretion of the geriatric expertise team);
- under the safeguard of justice;
- under tutorship or curatorship.
Key Trial Info
Start Date :
July 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2023
Estimated Enrollment :
223 Patients enrolled
Trial Details
Trial ID
NCT04020692
Start Date
July 16 2019
End Date
February 2 2023
Last Update
November 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Saint Vincent
Strasbourg, France, 67000
2
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67098